Evolvere BioSciences

Making Next-Generation Antibiotics that Outpace Bacterial Evolution

Oxford, United Kingdom · Founded 2021 · $500K raised

Headquarters
Oxford
Employees
1–10
Founded
2021
Total Funding
$500K
Last Round
$500K SeedSep 2024
Rounds
1

About

🦠🤖 We use our computational models to make next-generation antibiotics that outcompete bacterial evolution and precisely target pathogenic bacteria, without harming good microbes or human cells. ☠️ Current antibiotics stop working because bacteria evolve resistance to them. This makes drug-resistant bacteria a looming global health crisis - already killing more people than malaria and AIDS and it is getting exponentially worse 📈. 🧬 Our approach leverages co-evolutionary protein-protein interaction datasets combined with AI to forecast bacterial mutations and create ‘future-proof’ antibiotics, addressing antibiotic resistance before it develops. This changes the game for how frequently society will need to make new antibiotics and how long our new antibiotics will be able to treat patients 👩‍⚕️. We are a team of biochemists and evolutionary biologists who met at the University of Oxford.

Summary

Evolvere BioSciences is an Artificial Intelligence company based in Oxford, United Kingdom, founded in 2021. It has raised $500K in total across 1 round, most recently a $500K Seed round in Sep 2024. Investors include Y Combinator Continuity Fund and Cleo Capital.

Tech & App Stack

9 technologies & apps tracked

Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.

Sign up to view the funding chart

Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

SeedSeed RoundSep 2024
$500K

Investors

Similar Companies